Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening

Nowadays, the pharmacological therapy for the treatment of Chagas disease is based on two old drugs, benznidazole and nifurtimox, which have restricted efficacy against the chronic phase of the illness. To overcome the lack of efficacy of the traditional drugs (and their considerable toxicity), new...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietrich, Roque Carlos, Alberca, Lucas Nicolás, Ruiz, María Daniela, Palestro, Pablo Hernán, Carrillo, Carolina, Talevi, Alan, Gavernet, Luciana
Formato: Articulo Preprint
Lenguaje:Inglés
Publicado: 2018
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/101758
https://ri.conicet.gov.ar/11336/94472
Aporte de:
id I19-R120-10915-101758
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Química
Chagas disease
Cisapride
Docking
Drug repositioning
QSAR
TcPAT12
TcPOT1.1.
spellingShingle Química
Chagas disease
Cisapride
Docking
Drug repositioning
QSAR
TcPAT12
TcPOT1.1.
Dietrich, Roque Carlos
Alberca, Lucas Nicolás
Ruiz, María Daniela
Palestro, Pablo Hernán
Carrillo, Carolina
Talevi, Alan
Gavernet, Luciana
Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening
topic_facet Química
Chagas disease
Cisapride
Docking
Drug repositioning
QSAR
TcPAT12
TcPOT1.1.
description Nowadays, the pharmacological therapy for the treatment of Chagas disease is based on two old drugs, benznidazole and nifurtimox, which have restricted efficacy against the chronic phase of the illness. To overcome the lack of efficacy of the traditional drugs (and their considerable toxicity), new molecular targets have been studied as starting points to the discovery of new antichagasic compounds. Among them, polyamine transporter TcPAT12 (also known as TcPOT1.1) represents an interesting macromolecule, since polyamines are essential for Trypanosoma cruzi, the parasite that causes the illness, but it cannot synthesize them de novo. In this investigation we report the results of a combined ligand- and structure-based virtual screening for the discovery of new inhibitors of TcPAT12. Initially we filtered out ZINC and Drugbank databases with similarity and QSAR models and then we submitted the candidates to a validated docking based screening. Four structures were selected and tested in T. cruzi epimastigotes proliferation and two of them, Cisapride and [2-(cyclopentyloxy)phenyl]methanamine showed inhibitory effects. Additionally, we performed transport assays which demonstrated that Cisapride interferes with putrescine uptake in a specific mode.
format Articulo
Preprint
author Dietrich, Roque Carlos
Alberca, Lucas Nicolás
Ruiz, María Daniela
Palestro, Pablo Hernán
Carrillo, Carolina
Talevi, Alan
Gavernet, Luciana
author_facet Dietrich, Roque Carlos
Alberca, Lucas Nicolás
Ruiz, María Daniela
Palestro, Pablo Hernán
Carrillo, Carolina
Talevi, Alan
Gavernet, Luciana
author_sort Dietrich, Roque Carlos
title Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening
title_short Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening
title_full Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening
title_fullStr Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening
title_full_unstemmed Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening
title_sort identification of cisapride as new inhibitor of putrescine uptake in trypanosoma cruzi by combined ligand- and structure-based virtual screening
publishDate 2018
url http://sedici.unlp.edu.ar/handle/10915/101758
https://ri.conicet.gov.ar/11336/94472
work_keys_str_mv AT dietrichroquecarlos identificationofcisaprideasnewinhibitorofputrescineuptakeintrypanosomacruzibycombinedligandandstructurebasedvirtualscreening
AT albercalucasnicolas identificationofcisaprideasnewinhibitorofputrescineuptakeintrypanosomacruzibycombinedligandandstructurebasedvirtualscreening
AT ruizmariadaniela identificationofcisaprideasnewinhibitorofputrescineuptakeintrypanosomacruzibycombinedligandandstructurebasedvirtualscreening
AT palestropablohernan identificationofcisaprideasnewinhibitorofputrescineuptakeintrypanosomacruzibycombinedligandandstructurebasedvirtualscreening
AT carrillocarolina identificationofcisaprideasnewinhibitorofputrescineuptakeintrypanosomacruzibycombinedligandandstructurebasedvirtualscreening
AT talevialan identificationofcisaprideasnewinhibitorofputrescineuptakeintrypanosomacruzibycombinedligandandstructurebasedvirtualscreening
AT gavernetluciana identificationofcisaprideasnewinhibitorofputrescineuptakeintrypanosomacruzibycombinedligandandstructurebasedvirtualscreening
bdutipo_str Repositorios
_version_ 1764820440223580160